166 related articles for article (PubMed ID: 28599488)
1. Histone deacetylase inhibitor trichostatin A enhances the antitumor effect of the oncolytic adenovirus H101 on esophageal squamous cell carcinoma
Ma J; Li N; Zhao J; Lu J; Ma Y; Zhu Q; Dong Z; Liu K; Ming L
Oncol Lett; 2017 Jun; 13(6):4868-4874. PubMed ID: 28599488
[TBL] [Abstract][Full Text] [Related]
2. Coxsackievirus and adenovirus receptor promotes antitumor activity of oncolytic adenovirus H101 in esophageal cancer.
Ma J; Zhao J; Lu J; Jiang Y; Yang H; Li P; Zhao M; Liu K; Dong Z
Int J Mol Med; 2012 Dec; 30(6):1403-9. PubMed ID: 22992863
[TBL] [Abstract][Full Text] [Related]
3. A Tumor-Targeted Replicating Oncolytic Adenovirus Ad-TD-nsIL12 as a Promising Therapeutic Agent for Human Esophageal Squamous Cell Carcinoma.
Zhang Z; Zhang C; Miao J; Wang Z; Wang Z; Cheng Z; Wang P; Dunmall LSC; Lemoine NR; Wang Y
Cells; 2020 Nov; 9(11):. PubMed ID: 33182528
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of retinoblastoma in vitro and in vivo with conditionally replicating oncolytic adenovirus H101.
Song X; Zhou Y; Jia R; Xu X; Wang H; Hu J; Ge S; Fan X
Invest Ophthalmol Vis Sci; 2010 May; 51(5):2626-35. PubMed ID: 20007825
[TBL] [Abstract][Full Text] [Related]
5. The antitumor effects of oncolytic adenovirus H101 against lung cancer.
Lei J; Li QH; Yang JL; Liu F; Wang L; Xu WM; Zhao WX
Int J Oncol; 2015 Aug; 47(2):555-62. PubMed ID: 26081001
[TBL] [Abstract][Full Text] [Related]
6. An oncolytic adenovirus enhances antiangiogenic and antitumoral effects of a replication-deficient adenovirus encoding endostatin by rescuing its selective replication in nasopharyngeal carcinoma cells.
Liu RY; Zhou L; Zhang YL; Huang BJ; Ke ML; Chen JM; Li LX; Fu X; Wu JX; Huang W
Biochem Biophys Res Commun; 2013 Dec; 442(3-4):171-6. PubMed ID: 24269822
[TBL] [Abstract][Full Text] [Related]
7. Novel three-pronged strategy to enhance cancer cell killing in glioblastoma cell lines: histone deacetylase inhibitor, chemotherapy, and oncolytic adenovirus dl520.
Bieler A; Mantwill K; Dravits T; Bernshausen A; Glockzin G; Köhler-Vargas N; Lage H; Gansbacher B; Holm PS
Hum Gene Ther; 2006 Jan; 17(1):55-70. PubMed ID: 16409125
[TBL] [Abstract][Full Text] [Related]
8. The effects of trichostatin A on the oncolytic ability of herpes simplex virus for oral squamous cell carcinoma cells.
Katsura T; Iwai S; Ota Y; Shimizu H; Ikuta K; Yura Y
Cancer Gene Ther; 2009 Mar; 16(3):237-45. PubMed ID: 18949013
[TBL] [Abstract][Full Text] [Related]
9. Histone deacetylase inhibitor boosts anticancer potential of fusogenic oncolytic vaccinia virus by enhancing cell-cell fusion.
Nakatake M; Kurosaki H; Nakamura T
Cancer Sci; 2024 Feb; 115(2):600-610. PubMed ID: 38037288
[TBL] [Abstract][Full Text] [Related]
10. [Effect of CEA gene regulation on the anti-tumor activity of oncolytic adenovirus H101 to esophageal carcinoma].
Zheng H; Li MS; Zhao GQ; Dong ZM
Zhonghua Zhong Liu Za Zhi; 2011 Nov; 33(11):822-6. PubMed ID: 22335946
[TBL] [Abstract][Full Text] [Related]
11. Trichostatin A, a histone deacetylase inhibitor, suppresses proliferation and promotes apoptosis of esophageal squamous cell lines.
Ma J; Guo X; Zhang S; Liu H; Lu J; Dong Z; Liu K; Ming L
Mol Med Rep; 2015 Jun; 11(6):4525-31. PubMed ID: 25634603
[TBL] [Abstract][Full Text] [Related]
12. The histone deacetylase inhibitor panobinostat exerts anticancer effects on esophageal squamous cell carcinoma cells by inducing cell cycle arrest.
Cheng YW; Liao LD; Yang Q; Chen Y; Nie PJ; Zhang XJ; Xie JJ; Shan BE; Zhao LM; Xu LY; Li EM
Cell Biochem Funct; 2018 Dec; 36(8):398-407. PubMed ID: 30484863
[TBL] [Abstract][Full Text] [Related]
13. Enhancement of vaccinia virus based oncolysis with histone deacetylase inhibitors.
MacTavish H; Diallo JS; Huang B; Stanford M; Le Boeuf F; De Silva N; Cox J; Simmons JG; Guimond T; Falls T; McCart JA; Atkins H; Breitbach C; Kirn D; Thorne S; Bell JC
PLoS One; 2010 Dec; 5(12):e14462. PubMed ID: 21283510
[TBL] [Abstract][Full Text] [Related]
14. Histone deacetylase inhibitor FR901228 enhances the antitumor effect of telomerase-specific replication-selective adenoviral agent OBP-301 in human lung cancer cells.
Watanabe T; Hioki M; Fujiwara T; Nishizaki M; Kagawa S; Taki M; Kishimoto H; Endo Y; Urata Y; Tanaka N; Fujiwara T
Exp Cell Res; 2006 Feb; 312(3):256-65. PubMed ID: 16356494
[TBL] [Abstract][Full Text] [Related]
15. Recombinant oncolytic adenovirus H101 combined with siBCL2: cytotoxic effect on uveal melanoma cell lines.
Huang X; Jia R; Zhao X; Liu B; Wang H; Wang J; Zhou Y; Cun B; Ge S; Fan X
Br J Ophthalmol; 2012 Oct; 96(10):1331-8. PubMed ID: 22843987
[TBL] [Abstract][Full Text] [Related]
16. Reexpression of human somatostatin receptor gene 2 gene mediated by oncolytic adenovirus increases antitumor activity of tumor necrosis factor-related apoptosis-inducing ligand against pancreatic cancer.
Zhang Z; Huang Y; Newman K; Gu J; Zhang X; Wu H; Zhao M; Xianyu Z; Liu X
Clin Cancer Res; 2009 Aug; 15(16):5154-60. PubMed ID: 19671855
[TBL] [Abstract][Full Text] [Related]
17. HDAC inhibitor trichostatin A suppresses esophageal squamous cell carcinoma metastasis through HADC2 reduced MMP-2/9.
Wang F; Qi Y; Li X; He W; Fan QX; Zong H
Clin Invest Med; 2013 Apr; 36(2):E87-94. PubMed ID: 23544610
[TBL] [Abstract][Full Text] [Related]
18. The anti-tumor effects of dual PI3K/mTOR inhibitor BEZ235 and histone deacetylase inhibitor Trichostatin A on inducing autophagy in esophageal squamous cell carcinoma.
Wu N; Zhu Y; Xu X; Zhu Y; Song Y; Pang L; Chen Z
J Cancer; 2018; 9(6):987-997. PubMed ID: 29581778
[TBL] [Abstract][Full Text] [Related]
19. Selective inhibition of esophageal cancer cells by combination of HDAC inhibitors and Azacytidine.
Ahrens TD; Timme S; Hoeppner J; Ostendorp J; Hembach S; Follo M; Hopt UT; Werner M; Busch H; Boerries M; Lassmann S
Epigenetics; 2015; 10(5):431-45. PubMed ID: 25923331
[TBL] [Abstract][Full Text] [Related]
20. The oncolytic virus H101 combined with GNAQ siRNA-mediated knockdown reduces uveal melanoma cell viability.
Li Y; He J; Qiu C; Shang Q; Qian G; Fan X; Ge S; Jia R
J Cell Biochem; 2019 Apr; 120(4):5766-5776. PubMed ID: 30320917
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]